Omnia® Kinase Assays
![]() | Measure Kinase Activity in Real Time
|
Omnia® Kinase Assays utilize a fluorescence peptide substrate-based technology for the rapid, homogenous and sensitive detection of enzymatic activity. Results are measured under optimal kinetics, physiological (mM) ATP, and in real time without use of radioactive tracers or specialized equipment. Increases in kinase activity result in a corresponding increase in fluorescence. The kinetic format of the assay also corrects for false positives (compound auto fluorescence) and false negatives (quenching), minimizing interference. The assay can be used to select for both ATP-competitive and ATP non-competitive (allosteric) inhibitors. Omnia® Assays can be used with unmodified crude cell lysates, recombinant kinases or immunoprecipitated proteins.
Learn more about the Omnia® Kinase Principle.
For information on how to use Omnia® for analysis of cellular lysates or immunoprecipitated proteins, please contact us at discoverysciences@invitrogen.com.
Learn more about the Omnia® Kinase Principle.
For information on how to use Omnia® for analysis of cellular lysates or immunoprecipitated proteins, please contact us at discoverysciences@invitrogen.com.
| Kinase (112 total) | Best Kit | Alternatives |
|---|---|---|
| AKT1 | ST1 | ST4, ST5, ST6 |
| AKT2 | ST1 | ST4, ST5, ST6 |
| AKT3 | ST1 | ST4, ST5, ST6 |
| AMPK | ST23 | ST11 |
| ARK5 | ST31 | |
| AURORA A | ST16 | ST5 |
| AURORA B | ST16 | |
| AURORA C | ST16 | |
| BRSK1 | ||
| CAMK1D (CAMKIδ) | ST23 | |
| CAMK2A (CAMKIIα) | ST23 | |
| CAMK2D (CAMKIIδ) | ST23 | |
| CDC42BPA (MRCK/DMPK) | ST18 | |
| CDC42BPB (MRCK/DMPK) | ST18 | |
| CDK1/CyclinB | ST7 | |
| CDK1/CyclinE | ST7 | |
| CDK2/CyclinA | ST7 | |
| CDK2/CyclinE | ST7 | |
| CDK4/CyclinD1 | ||
| CDK5/p25NCK | ST7 | |
| CDK5/p35 | ST7 | |
| CDK6/CyclinD1 | ||
| CHEK1 (CHK1) | ST11 | ST1, ST3 |
| CHEK2 (CHK2) | ST3 | ST11 |
| CLK2 | ST15 | |
| CLK3 | ST15 | |
| CSNK1A1 (CK1) | ST24 | |
| CSNK1D (CKIδ) | ST24 | |
| CSNK1E (CK1ε) | ST24 | |
| CSNK1G1 (CK1γ1) | ST24 | |
| CSNK1G2 (CK1γ2) | ST24 | ST21 |
| CSNK1G3 (CK1γ3) | ST24 | ST21 |
| CSNK2A1 (CK2α1) | ST22 | ST21 |
| DAPK3 | ST1 | |
| DCAMKL2 | ||
| DYRK1A | ||
| GSK3α | ST13 | |
| GSK3β (C-terminal His) | ST13 | |
| IKKβ (IKK2) | ST20 | ST19 |
| IKKε | ST24 | ST12, ST16 |
| MAP3K10 (MLK2) | ST6 | ST1, ST5 |
| MAP3K11 (MLK3) | ST8 | |
| MAP3K9 (MLK1) | ST8 | |
| MAP4K2 (GCK) | ST25 | ST26 |
| MAP4K4 (HGK) | ST32 | ST26 |
| MAP4K5 (KHS1) | ST26 | ST25 |
| MAPK1 (ERK2) | ST17 | ST9 |
| MAPK10 (JNK3) | ST10 | |
| MAPK11 (p38β) | ST9 | |
| MAPK12 (p38γ) | ST7 | ST9, ST10 |
| MAPK13 (p38δ) | ST10 | |
| MAPK14 (p38α) | ||
| MAPK3 (ERK1) | ST17 | |
| MAPK8 (JNK1) | ST10 | |
| MAPKAP-K2 (MK2) | ST3 | |
| MAPKAP-K3 | ST3 | ST11 |
| MAPKAP-K5 (PRAK) | ST3 | |
| MARK2 | ST31 | |
| MINK1 | ST8 | |
| MLK1 | ST8 | |
| MLK3 | ST8 | |
| NEK1 | ||
| NEK2 | ||
| NEK4 | ||
| NEK6 | ST27 | |
| NEK9 | ||
| PAK1 | ST5 | ST1, ST6 |
| PAK2 | ST5 | |
| PAK3 | ST5 | |
| PAK4 | ST5 | |
| PAK6 | ST5 | |
| PAK7 | ST5 | |
| PASK | ST6 | ST1, ST4, ST15 |
| PHKG1 | ST3 | |
| PHKG2 | ST3 | ST11, ST15 |
| PIM1 | ST26 | |
| PIM2 | ST14 | ST15 |
| PKA | ST5 | ST1, ST6 |
| PKCα | ST8 | |
| PKCβI | ST8 | |
| PKCβII | ST8 | |
| PKCδ | ST8 | |
| PKCε | ST8 | |
| PKCη | ST8 | ST15 |
| PKCγ | ST8 | |
| PKCι | ST8 | |
| PKCθ | ST8 | |
| PKCζ | ST8 | |
| PKCμ | ST8 | ST3, ST11 |
| PKN1 (PRK1) | ST18 | |
| PRKCN (PKD3) | ST8 | ST3 |
| PRKD2 | ST8 | ST3, ST11 |
| PRKG1 | ST5 | |
| PRKG2 | ST5 | ST1, ST4 |
| PRKX | ST5 | ST1, ST6 |
| ROCK1 | ST5 | ST14 |
| ROCK2 | ST5 | ST6 |
| RPS6KA1 (RSK1) | ST6 | ST1, ST5 |
| RPS6KA2 (RSK3) | ST6 | ST1, ST5 |
| RPS6KA3 (RSK2) | ST6 | ST1, ST5 |
| RPS6KA5 (MSK1) | ST1 | ST4, ST5, ST6 |
| RPS6KA6 (RSK4) | ST6 | ST1, ST5 |
| RPS6KB1 (p70S6K) | ST6 | ST18 |
| SGK (SGK1) | ST1 | ST4, ST5, ST6 |
| SGK2 | ST4 | ST1, ST5, ST6 |
| SGKL (SGK3) | ST4 | ST1, ST5, ST6 |
| STK22B (TSSK2) | ST31 | |
| STK22D (TSSK1) | | |
| STK3 (MST2) | | |
| STK4 (MST1) | | |
| TAOK2 (TAO1) | | |
| TBK1 (IKK-ε) | ST12 |
| Cascade Assays Kinase (19 total) | Direct | Substrate |
|---|---|---|
| b-RAF | ST3 | |
| b-RAF, Catalytic | ST3 | |
| c-RAF (RAF1) | ST3 | |
| MAP2K1 (MEK1) | ST3 | |
| MAP2K2 (MEK2) | ST3 | |
| MAP2K6 (MKK6) | ST3 | |
| MAP3K2 (MEKK2) | ST3 | |
| MAP3K3 (MEKK3) | ST3 | |
| MAP3k8 (COT) | ST3 | |
| MAPK1 (ERK2) | ST17 | ST3 |
| MAPK11 (p38β) | ST9 | ST3 |
| MAPK12 (p38γ) | ST7 | ST3 |
| MAPK13 (p38δ) | ST3 | |
| MAPK14 (p38α) | ST3 | |
| MAPK3 (ERK1) | ST17 | ST3 |
| MAPK8 (JNK1) | ST10 | ST3 |
| MAPK9 (JNK2) | ST3 | |
| MAPK10 (JNK3) | ST10 | ST3 |
| PDK1 | ST1 |
| Kinase (77 total) | Best Kit | Alternatives |
|---|---|---|
| ABL1 | Y6 | Y1, Y5, Y7 |
| ABL1 E255K | Y6 | |
| ABL1 G250E | Y6 | |
| ABL1 T315I | Y6 | |
| ABL1 Y253F | Y6 | |
| ABLl2 (ARG) | Y6 | Y5 |
| ALK | Y4 | |
| AXL | Y11 | |
| BLK | Y5 | Y6, Y14 |
| BMX | Y5 | |
| BTK | Y5 | Y6 |
| CSF-1R (FMS) | Y9 | Y12 |
| EGFR (ErbB1) | Y12 | Y7 |
| EGFR T790M | Y12 | |
| EGFR L858R | Y10 | Y12 |
| EGFR L861Q | Y12 | Y7, Y9 |
| EGFR1 | Y7 | Y8 |
| EPHA1 | Y6 | Y5 |
| EPHA2 | Y5 | Y3 |
| EPHA4 | Y12 | Y3 |
| EPHA5 | ||
| EPHA8 | Y12 | Y5 |
| EPHB1 | Y6 | Y5 |
| EPHB2 | Y6 | Y14 |
| EPHB3 | Y6 | Y5 |
| EPHB4 | Y5 | Y6 |
| FER | Y5 | Y4 |
| FGFR1 | Y12 | Y7, Y8 |
| FGFR2 | Y11 | |
| FGFR3 | Y11 | |
| FGFR3 K650E | Y12 | Y8, Y9 |
| FGFR4 | Y10 | Y11 |
| FGR | Y5 | Y1, Y12 |
| FLT1 (VEGFR1) | Y8 | Y7 |
| FLT3 CD | Y5 | Y4, Y14 |
| FLT3 D835Y | Y5 | Y9 |
| FLT4 (VEGFR3) | Y8 | Y7, Y12 |
| FRK | Y5 | Y9, Y12 |
| FYN | Y5 | Y2 |
| HCK | Y5 | Y2 |
| IGF-1R | Y4 | Y11, Y12 |
| IR (Insulin Receptor) | Y4 | Y11, Y12 |
| IRR (Insulin-related receptor) | Y4 | Y12 |
| ITK | Y6 | Y14 |
| JAK2 | Y11 | Y7, Y10 |
| JAK2 JH1 JH2 | Y12 | |
| JAK2 JH1 JH2 V617F | Y12 | Y7 |
| JAK3 | Y7 | Y12 |
| KDR (VEGFR2) | Y8 | Y7, Y12 |
| KIT | Y9 | Y10, Y12 |
| KIT T670I | Y12 | Y9, Y10 |
| LCK | Y5 | Y6, Y14 |
| LYN A | Y5 | Y1 |
| LYN B | Y5 | Y1 |
| MERTK (cMER) | Y6 | Y9, Y12, Y14 |
| MET (HGFR) | Y12 | Y14 |
| MET (HGFR) M1250T | Y9 | Y12, Y14 |
| MST1R | Y8 | |
| MUSK | Y1 | Y4 |
| NTRK1 (TRKA) | Y8 | Y11, Y4 |
| NTRK2 (TRKB) | Y5 | Y6, Y12 |
| PDGFRA (PDGFRα) | Y9 | Y1, Y12 |
| PDGFRA D824V | Y9 | Y12, Y14 |
| PDGFRB (PDGFRβ) | Y14 | Y6 |
| PTK2 (FAK) | Y3 | Y2 |
| RET | Y12 | Y7 |
| RET V804L | Y8 | |
| RET Y791F | Y11 | Y7 |
| ROS1 | Y4 | Y12, Y11 |
| SRC | Y2 | |
| SRCN2 | ||
| SRMS | Y12 | Y6, Y14 |
| SYK | Y7 | Y12 |
| TEK (tie2) | Y8 | Y5 |
| TYRO3 (RSE) | Y5 | |
| YES | Y5 | Y2, Y8 |
| ZAP70 | Y8 |
Table 1. Ordering information for reagents
| Reagents | Cat. No. |
|---|---|
| Omnia® Ser/Thr Reaction Buffer | KB001A |
| Omnia® Tyr reaction Buffer | KB002A |
| Omnia® ATP Solution | AS001A |
Omnia® Custom and Bulk Substrate Services
Should you not find your substrate of interest, Invitrogen also offers custom services for the generation of Omnia® peptide substrates. Omnia® substrates can be successfully produced for a wide variety of kinases. We also can provide milligram quantites of lyophilized substrate for your large screening projects.
Please contact us at discoverysciences@invitrogen.com for more information about these services or to request a quotation.
Please contact us at discoverysciences@invitrogen.com for more information about these services or to request a quotation.
Technical Resources


